Valuation: MRI Interventions Inc

Market Cap 451M 396M 368M 339M 635M 43.65B 647M 4.4B 1.72B 21.29B 1.69B 1.66B 73.86B P/E 2026 *
-13.5x
P/E 2027 * -16x
Enterprise Value 451M 396M 368M 339M 635M 43.65B 647M 4.4B 1.72B 21.29B 1.69B 1.66B 73.86B EV / Sales 2026 *
8.48x
EV / Sales 2027 * 7.03x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 2017-11-06
Director of Finance/CFO 41 2020-12-31
Chief Tech/Sci/R&D Officer - 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2014-03-09
Chairman 80 2021-02-03
Director/Board Member 49 2017-11-06
Change 5-day change 1-year change 3-year change Capi.($)
+24.88%-8.05% - - 451M
+8.71%+5.36%+22.63%+0.14% 196B
+7.46%-6.10%-2.72%-25.38% 126B
-2.54%-17.48%-33.85%+2.61% 120B
+1.42%-2.33%-59.56%-16.47% 63.87B
-0.65%-4.58%+8.98%-8.29% 48.58B
-1.56%-2.07%-25.50%-33.72% 43.93B
+4.71%+2.67%+16.97%+9.41% 37.69B
+3.13%+1.12%+29.35%+33.26% 36.41B
+3.14%+3.47%+88.18%+4.67% 28.88B
Average +4.52%-3.39%+4.94%-3.75% 77.92B
Weighted average by Cap. +3.62%-4.99%-0.32%-5.83%

Financials

2026 *2027 *
Net sales 53.13M 46.73M 43.41M 39.93M 74.88M 5.15B 76.22M 519M 202M 2.51B 199M 195M 8.71B 64.1M 56.38M 52.37M 48.17M 90.33M 6.21B 91.95M 626M 244M 3.03B 241M 235M 10.5B
Net income -33.07M -29.08M -27.02M -24.85M -46.6M -3.2B -47.43M -323M -126M -1.56B -124M -121M -5.42B -28.63M -25.18M -23.39M -21.52M -40.35M -2.77B -41.07M -280M -109M -1.35B -107M -105M -4.69B
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-